Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …
Feature
gsk_good_smaller

GSK fined millions over deals to delay generic competition

February 12, 2016 Medical Communications, Sales and Marketing GSK seroxat

GlaxoSmithKline has been fined £37.6m by the UK Competition & Markets Authority (CMA) for paying two generic drugmakers to delay …
News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016 Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …
News
abpi_logo

ABPI appoints Mike Thompson as new chief executive

February 11, 2016 Medical Communications

The Association of the British Pharmaceutical Industry (ABPI) has appointed former GlaxoSmithKline executive Mike Thompson as its new chief executive …
Appointment
carol_lynch

Sandoz’s Carol Lynch elected to chair European Biosimilars Group

February 10, 2016 Medical Communications biosimilars

The European Generic Medicines Association (EGA) has elected Carol Lynch, global head of Biopharmaceuticals & Oncology Injectables at Sandoz, as …
Appointment

NICE publishes new myeloma guidance

February 10, 2016 Medical Communications, Research and Development Farydak, Novartis, multiple myeloma

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. Myeloma …
News

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016 Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

New breast cancer initiative brings together pharma and Europe’s top researchers

February 9, 2016 Medical Communications, Research and Development Pfizer, breast cancer

The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …
News
aedes_aegypti_mosquito

INTERVIEW: Tackling the Zika threat

February 9, 2016 Manufacturing and Production, Medical Communications Zika, vaccines

The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …
Feature
uganda_health_minister_sarah_opendi_at_merck_uganda_cancer_day

Merck partners with Ugandan Health Ministry to tackle cancer awareness

February 8, 2016 Manufacturing and Production, Medical Communications Africa, Cancer, Merck

Germany’s Merck celebrated World Cancer Day by collaborating with the Uganda Ministry of Health to raise awareness about early detection …
News
jeremy_hunt_appears_on_thye_bbcs_andrew_marr_show_february_7

UK Health Secretary sets out £4.2 billion ‘digital NHS’ vision

February 8, 2016 Medical Communications, Sales and Marketing Jeremy Hunt, NHS

UK Health Secretary Jeremy Hunt has announced a £4.2 billion investment in the National Health Service (NHS) which will help …
News
Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016 Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …
News

Parliamentary committee says CDF must make better use of taxpayer money

February 5, 2016 Medical Communications Cancer Drugs Fund, Public Accounts Committee

The Cancer Drugs Fund, set up to improve patients’ access to cancer drugs, has not been managed effectively, a UK …
News
Lundbeck HQ

Lundbeck gets go-ahead for US and EU licence expansions

February 4, 2016 Medical Communications, Sales and Marketing Abilify, EMA, FDA, Lundbeck, Otsuka, Takeda, aripiprazole, brintellix, vortioxetine

Lundbeck has earned two recommendations from regulatory committees of the FDA and the EMA, which both recommended the company’s drugs …
News
Xarelto

Investigation questions Xarelto trial data accuracy

February 4, 2016 Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban

The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025